OraSure Technologies, Inc. reported strong financial results for the fourth quarter of 2020, with revenue increasing by 41% compared to the same period in the previous year. The company's growth was primarily driven by increased demand for molecular collection devices, as well as strong performance in diagnostics. OraSure is optimistic about its future prospects and expects continued growth in the coming years.
OraSure's Q4 2020 revenue increased by 41% year-over-year.
Molecular collection devices revenue grew significantly, driven by increased demand.
Diagnostics segment demonstrated strong performance.
The company is optimistic about future growth prospects.
OraSure expects revenue for the first quarter of 2021 to be between $58 million and $61 million.
Analyze how earnings announcements historically affect stock price performance